The startup was co-founded in 2017 by Younger and CTO Randolph Lopez, using the technology they helped to develop while graduate researchers at the UW. A-Alpha Bio employs 45 people, up from 13 ...

BOSTON, September 06, 2024--PureTech Founded Entity Vor Bio Announces New Clinical Data Validating Approach of Using Shielded Transplants to Deliver Targeted Therapies ...

Charles River Laboratories International, Inc. CRL has announced the integration of Akron Bio’s (Akron) Closed System Solutions (CSS) line of liquid cytokines produced under current good ...

Translate Bio is seeking to push the field forward in another area through a phase 1/2 clinical trial that is testing a drug, MRT5005, that encodes for the CFTR gene that underpins cystic fibrosis.

Kronos Bio (KRON) announced preclinical data from its p300 KAT inhibitor program for human papillomavirus-driven tumors at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics.

Building roots in glass, a bio-inspired approach to creating 3D microvascular networks using plants and fungi. ScienceDaily . Retrieved June 11, 2025 from www.sciencedaily.com / releases / 2024 ...

Upstream Bio's IPO raised ~$293m, focusing on developing verekitug, a unique TSLP receptor antagonist for severe respiratory disorders, now in Phase 2 trials. The company has a strong cash ...

Nuvation Bio Inc. (NYSE: ... Nuvation Bio To Present New Data from Pivotal Clinical Studies of Taletrectinib in Advanced ROS1-Positive Non-Small Cell Lung Cancer at ASCO 2025 Annual Meeting.

Cabaletta Bio, Inc., a clinical-stage biotechnology company focused on targeted cell therapies for autoimmune diseases, announced that updated clinical data on its investigational therapy ...